Evidence map›Paper›PMID 12154402›Full record

ReviewOncogene2002

Methyl-CpG binding proteins and cancer: are MeCpGs more important than MBDs?

Egor Prokhortchouk, Brian Hendrich

Abstract readReview
PubMed Publisher
In one paragraph

Review in Oncogene, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Epigenetic silencing of methyl-CpG-binding protein 2 gene affects proliferation, invasion, migration, and apoptosis of human osteosarcoma cells.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2014
    Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Egor ProkhortchoukGroup of Transcriptional Control and Oncogenesis, Institute of Gene Biology, Vavilova 34/5, 117334 Moscow, Russian Federation.
Brian Hendrich

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Chromosomal Proteins, Non-HistoneBase Pair MismatchCell NucleusCytoplasmDisease ProgressionDNA-Binding ProteinsDNA MethylationDNA, NeoplasmDNA RepairEndodeoxyribonucleasesGene Expression RegulationHumansMethyl-CpG-Binding Protein 2NeoplasmsRepressor ProteinsChromosomal Proteins, Non-HistoneDNA-Binding ProteinsDNA, NeoplasmEndodeoxyribonucleasesMBD4 protein, humanMECP2 protein, humanMethyl-CpG-Binding Protein 2Repressor Proteins

Identifiers

PMID12154402

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.